This is the authors' abstract. We don't add key points for this paper.
The management of retinitis pigmentosa (RP) and its progression has always been a difficult issue, but promising developments have been shown by the use of mesenchymal stem cells (MSCs). It has thus been evidenced how these cells have significant paracrine and immunomodulatory properties: they secrete trophic factors that stimulate RPE or that are similar to those produced by RPE.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Antonio Florido (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: